PharmaShots | Incisive News in 3 Shots

Subscribe Now

obsidian therapeutics

Obsidian Therapeutics’ OBX-115 Receives the US FDA’s Fast Track Designation to Treat Advanced Melanoma

Obsidian Therapeutics’ OBX-115 Receives the US FDA’s Fast Track Designation to Treat Advanced Melanoma

July 10, 2024

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us